Citation Impact
Citing Papers
The human disease network
2007 Standout
Protein stability promotes evolvability
2006 StandoutNobel
Phospholipid methylation controls Atg32‐mediated mitophagy and Atg8 recycling
2015 StandoutNobel
Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
2001
Molecular Organization of Drosophila Neuroendocrine Cells by Dimmed
2011 StandoutNobel
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
2001
Genome-wide features of neuroendocrine regulation in Drosophila by the basic helix-loop-helix transcription factor DIMMED
2015 StandoutNobel
Treatment of kidney cancer
2009 StandoutNobel
Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
2000
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Nephrogenic Diabetes Insipidus
2006
Recent advances in our understanding of neurodegeneration
2009
Kidney stones: pathophysiology and medical management
2006 Standout
ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency
2007
Mis-translation of a Computationally Designed Protein Yields an Exceptionally Stable Homodimer: Implications for Protein Engineering and Evolution
2006 StandoutNobel
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
1989 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
2011 StandoutNobel
Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
1998
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs
2009
Taking advantage of luminescent lanthanide ions
2005 Standout
Neurexins Physically and Functionally Interact with GABAA Receptors
2010 StandoutNobel
Human and mouse mitochondrial orthologs of bacterial ClpX
2000
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
2002 StandoutNobel
Inactivation of Conserved C. elegans Genes Engages Pathogen- and Xenobiotic-Associated Defenses
2012 StandoutNobel
Genetic control of the circulating concentration of transforming growth factor type beta1
1999
‘Sticky feet’-directed mutagenesis and its application to swapping antibody domains
1989 StandoutNobel
NARC-1/PCSK9 and Its Natural Mutants
2004
Chaperone overload is a possible contributor to ‘civilization diseases’
2001
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆
2000
Mitochondria: In Sickness and in Health
2012 Standout
Nephrogenic diabetes insipidus
1998
Protein folding and misfolding
2003 StandoutNature
Molecular chaperones in protein folding and proteostasis
2011 StandoutNature
Lipid Storage Myopathy due to Glutaric Aciduria Type II: Treatment of a Potentially Fatal Myopathy
1988
Cytokine gene polymorphism in human disease: on-line databases
1999
Osteoclast differentiation and activation
2003 StandoutNature
Mechanism of lid closure in the eukaryotic chaperonin TRiC/CCT
2008
Cardiovascular Risk Reduction in High-Risk Pediatric Patients
2006
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
1993
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Action of the Chaperonin GroEL/ES on a Non-native Substrate Observed with Single-Molecule FRET
2010 StandoutNobel
Control of mitochondrial β-oxidation flux
2002
Aquaporin water channels – from atomic structure to clinical medicine
2002 StandoutNobel
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
1999 StandoutNature
Mechanism of folding chamber closure in a group II chaperonin
2010 StandoutNatureNobel
AFLP: a new technique for DNA fingerprinting
1995 Standout
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
2006 Standout
Missense meanderings in sequence space: a biophysical view of protein evolution
2005
Mitochondrial quality control: a matter of life and death for neurons
2012
Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase
2002 StandoutNobel
Diagnosis of α1antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products
1988
Endoplasmic Reticulum Retention and Associated Degradation of a GABAA Receptor Epilepsy Mutation That Inserts an Aspartate in the M3 Transmembrane Segment of the α1 Subunit
2005
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Mouse models of mitochondrial dysfunction and heart failure
2004
Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family.
1987
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
1997 Standout
Nuclear Receptor Signaling and Cardiac Energetics
2004
Garrod's foresight; our hindsight
2001
Time-Resolution in Fluorometry Technologies, Labels, and Applications in Bioanalytical Assays
2001
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
KEGG: integrating viruses and cellular organisms
2020 Standout
How mitochondria produce reactive oxygen species
2008 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures
2002
Fatty acid monooxygenation by cytochrome P-450BM-3.
1990
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
2001
Multiscale natural moves refine macromolecules using single-particle electron microscopy projection images
2012 StandoutNobel
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
2002 StandoutNobel
Peroxisome Biogenesis Disorders
2003
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Three Hamster Species with Different Scrapie Incubation Times and Neuropathological Features Encode Distinct Prion Proteins
1990 StandoutNobel
Subunit order of eukaryotic TRiC/CCT chaperonin by cross-linking, mass spectrometry, and combinatorial homology modeling
2012 StandoutNobel
Activation of C−H Bonds by Metal Complexes
1997 Standout
Association of a Polymorphism of the Transforming Growth Factor-β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women
1998
Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses
2002
The mitochondrial UPR – protecting organelle protein homeostasis
2010
Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins.
1990 StandoutNobel
The Hsp70 and TRiC/CCT Chaperone Systems Cooperate In Vivo To Assemble the Von Hippel-Lindau Tumor Suppressor Complex
2003
Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts.
1985
Symmetry-free cryo-EM structures of the chaperonin TRiC along its ATPase-driven conformational cycle
2011 StandoutNobel
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Structure-guided SCHEMA recombination generates diverse chimeric channelrhodopsins
2017 StandoutNobel
Works of N. Gregersen being referenced
LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia
2002
A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women
1997
A polymerase chain reaction-based method for the semiquantitative study of interleukin-8 mRNA in human basophil leukocytes
1995
Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13)
2008
Detection of alpha1-antitrypsin genotypes by analysis of amplified DNA sequences
1988
DNA deletions in the low density lipoprotein (LDL) receptor gene in Danish families with familial hypercholesterolemia
1991
Ethylmalonic Aciduria Is Associated with an Amino Acid Variant of Short Chain Acyl-Coenzyme A Dehydrogenase
1996
Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism
1994
A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia
2007
On the Biologic Origin of C6-C10-Dicarboxylic and C6-C10-ω-1-Hydroxy Monocarboxylic Acids in Human and Rat with Acyl-CoA Dehydrogenation Deficiencies: in Vitro Studies on the ω- and ω-1-Oxidation of Medium-Chain (C6-C12) Fatty Acids in Human and Rat Liver
1983
Protein misfolding disorders: Pathogenesis and intervention
2006
Lipid‐storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late‐onset multiple acyl‐CoA dehydrogenation deficiency
2004
Defective folding and rapid degradation of mutant proteins is a common disease mechanism in genetic disorders
2000
Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency.
1990
In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase
1982
Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.
1996
Improved RNase protection assay for quantifying LDL-receptor mRNA; estimation of analytical imprecision and biological variance in peripheral blood mononuclear cells
1995
Detection of a point mutation using short oligonucleotide probes in allele-specific hybridization.
1994
C6—C10-Dicarboxylic Aciduria: Investigations of a Patient with Riboflavin Responsive Multiple Acyl-CoA Dehydrogenation Defects
1982
The role of chaperone‐assisted folding and quality control in inborn errors of metabolism: Protein folding disorders
2001
Biochemical studies in a patient with defects in the metabolism of acyl‐CoA and sarcosine: Another possible case of glutaric aciduria type II
1980